1-hydroxybenzotriazole hydrate (HOBt), 2,2,2-trifluoroethanethiol (TFET), 2-mercaptoethanol (βME) Resin (100-200 mesh) and 2-chlorotrityl chloride resin were from Novabiochem.
2-log ladder, BsaI-HF, dNTP set, DpnI, DraIII-HF, EcorV-HF, Phusion High-fidelity DNA polymerase, Q5 DNA polymerase, RNAse A, T4 DNA ligase, T5 DNA exonuclease, Taq DNA ligase, DH5a, BL21 DE3, BL21(DE3)plysS and BL21 Rosetta 2 chemically competent cells were distributed through BioConcept from New England Biolabs.
Instruments
An HT Infors AG incubator was used for incubation of bacteria in protein expression. Cells were harvested for further processing in 1L centrifuge tubes using an Avanti J-20 XPI centrifuge from Beckman Coulter. Lysis was carried out with a Vibra-cell VCX 750 Sonics & Materials sonicator.
Size exclusion chromatography and ion exchange purification was performed on an AKTA Pure FPLC system from GE Healthcare. Size-exclusion was done using an S200 10/300GL column from GE Healthcare using isocratic elution with a flow rate of 0.5 mL/min over 1.05 column volumes and collected as 250 μL fractions in 96-well plates. Cation exchange purifications were done using HiTrap SP HP (5 mL) columns from GE Healthcare.
Reaction vessels from Peptides International were used for manual steps in solid-phase peptide synthesis and the automated parts done on a Tribute instrument from Peptides International Inc. An Agilent 1260 series instrument with an Agilent Zorbax C18 column (5 µm, 4.6 x 150 mm) was used for analytical reversed phase high-performance liquid chromatography (RP-HPLC). The mobile phases used were 0.1% TFA in water (RP-HPLC solvent A), and 90% acetonitrile, 0.1% TFA in water (RP-HPLC solvent B). Typically a gradient of 0-70% solvent B over 30 min at a flow rate of 1 mL/min was used. Preparative scale purifications were similarly conducted on Agilent 1260 preparative HPLC systems. A Zorbax C18 preparative column (7 μm, 21.2 x 250 mm) or a semi-preparative column (5 μm, 9.4 x 250 mm) was employed at flow rates of 20 mL/min or 4 mL/min, respectively. Absorbance spectra were recorded with an Agilent 8453 UV-Vis spectrophotometer. SDS-PAGE, native PAGE and agarose gels were imaged using a ChemiDoc MP imaging system from BioRad. Fluorescence spectra were acquired with a Fluorolog®-3 spectrofluorometer (Horiba Jobin Yvon).
Single-molecule experiments were performed on a micro-mirror TIRF system 1 (MadCityLabs) using Coherent Obis Laser lines at 405 nm, 488 nm, 532 nm and 640 nm, a 100x NA 1.49 Nikon CFI Apochromat TIRF objective (Nikon) as well as an iXon Ultra EMCCD camera (Andor), operated by custom-made Labview (National Instruments) software.
Methods

Synthesis of peptide 2
2: H2A.X 135-142 (S139ph, A135C): CTQAS(ph)QEY Automated peptide synthesis of peptide 2 was performed using a Tribute peptide synthesizer on a 0.1 mmol scale using preloaded Fmoc-Tyr(tBu)-Wang resin. Following a general protocol, amino acids were used in a 5 equivalent (eq.) excess for coupling. β-branched amino acids and arginines were double-coupled. Fmocdeprotection was achieved with 20 % (v/v) piperidine in DMF. In the automated synthesis, amino acids were dissolved with 4.8 eq. HBTU and 10 eq. DIPEA in DMF, added to the resin and coupled for 30 min. The resin was washed with DMF between coupling and deprotection steps. Following completion of the synthesis, resins were washed with DMF, DCM and MeOH and dried. The peptide was cleaved from the resin by incubation with 10 mL/g of a mixture of TFA/TIS/H 2 O (95/2.5/2.5%) for 3 h at RT and filtered through a frit.
Crude peptides were precipitated by addition of cold diethyl ether, followed by centrifugation and dissolving of the pellet in 50% ACN. The crude peptide was lyophilized, followed by purification by analytical HPLC For the introduction of K15 ubiquitylation, the N-terminal tail of H2A.X was synthesized as a C-terminal hydrazide, and carrying a cysteine attached to the ε-amino group of lysine 15.
Preparation of pre-loaded hydrazine resin
Hydrazide resin was prepared as described 2 . Briefly, 0.85 mmol 2-chlorotrityl chloride resin reacted with 2.55 mmol (444 µL) DIPEA and 2.6 mmol hydrazine monohydrate (82 µL) in DMF at 0° C. Unreacted resin was capped with methanol and washed with DMF. 1 g of Fmoc-Lys(Boc)-OH (5 eq., 2.125 mmol) was weighed into a vial, activated with HBTU and DIPEA (4.3 mmol, 740 µmol) and added to the resin. Coupling was allowed to proceed for 30 min, repeated with 2 equivalents of amino acid, followed by washes with DMF, DCM and methanol before drying in a desiccator. Resin loading was determined by deprotection of the Fmoc with 20%
piperidine and measurement at 301 nm in triplicate samples.
Peptide synthesis of 5a
The automated synthesis of 5a was performed as described above for peptide 2. After automated synthesis, a cysteine was coupled to the ε-amino group of lysine 15 for ubiquitin coupling. were activated with 4.76 eq. of HATU from a 0.5 M stock in DMF for 2 min and 10 eq. DIPEA for 1 min followed by addition to the resin and incubation with stirring for 30 min. Coupling of Boc-Cys(Trt)-OH to the ε-amino group of lysine 15 was repeated and the resin washed with DMF,DCM and methanol before drying in a desiccator. Peptide 5a was cleaved from the resin as described for peptide 2 (above), purified by preparative RP-HPLC and analyzed by analytical RP-HPLC ( Figure S2g ) and ESI-MS (Figure S2h,i) .
Semi-synthesis of H2A.X(1-20)K15ub, 5b
Recombinant production of Ub-MES
Ubiquitin(1-75) was cloned in frame with a single-chain version of the split-intein Npu, containing a Cterminal mutation of the catalytic asparagine and the +1 cysteine (in the extein) to alanine:
The construct was expressed in BL21(DE3)plysS cells (induction for 4h with 0.5 mM IPTG), the cells were lysed and the Ub-intein fusion was purified over a Ni:NTA affinity column. The protein was eluted with 600 mM imidazole in 20 mM Tris-HCl, pH 6.8 and 200 mM NaCl elution buffer. 100 mM MESNa and 1 mM TCEP were added and the intein cleavage was let to proceed overnight. Ub-MES was purified by preparative RP-HPLC 
DLMRVDNLPHHHHHH
Protein 1a was expressed in T7 express cells from a pet3a plasmid. Cell cultures were grown at 37°C in LB media supplemented with 100 μg/mL ampicillin until an OD600 of 0.6 was reached. Protein expression and purification was performed following ref.
3
. Briefly, expression was induced by addition of IPTG to a final concentration of 0.5 mM. Expression of the protein was allowed to continue until 3 h post-induction. Cells were harvested, cell pellets were resuspended in lysis buffer (20 mM Tris-HCl, pH 7.5, 1 mM EDTA, 200 mM NaCl, 1 mM βME, 1 Roche EDTA-free protease inhibitor tablet / 50mL). Cells were lysed by freeze-thawing and sonication. The inclusion body pellet was washed twice with 7.5mL of histone lysis buffer with 1% triton-X and once without triton-X.
The inclusion body pellet was subsequently resolubilized in 10 mL resolubilization buffer (6 M GdmHCl, 50mM Tris-HCl, pH 7.5, 150 mM NaCl, 2.5 mM imidazole) for 20min, then centrifuged for 10 min at 21000 x g to recover the supernatant, which was transferred to an equilibrated HisTrap FF column. The column was washed with wash buffer (resolubilization buffer + 50 mM imidazole) and then eluted with 15mL of elution buffer (resolubilization buffer + 500 mM imidazole). The eluted protein was purified by preparative RP-HPLC and analyzed by analytical RP-HPLC ( Figure S1a ) and ESI-MS (Figure S1b-c) .
Expression and purification of Npu C peptide
The Npu C peptide, in fusion to the GyrA intein and containing a dual alanine mutation (Npu C -AA-GyrA-6xH) was prepared as previously described 
SUMO protease Ulp1 expression
Ulp1 was expressed and inclusion bodies were prepared using the same protocol as for protein 1a. Inclusion bodies were resolubilized in imidazole resolubilization buffer (6 M GdmHCl, 50 mM Tris pH 7.5, 100mM NaCl, 5mM imidazole) and the insoluble cell debris removed by centrifugation. The supernatant was loaded onto pre-equilibrated Ni-NTA resin (~1mL). The resin was allowed to bind for 45-60 min, followed by washes with 3 x 5 CV of resolubilization buffer with 25 mM imidazole, and finally by elution with 4 x 2CV of the same buffer in 300 mM imidazole. The purified Ulp1 enzyme was immediately used without further purification.
One-pot ligation and SUMO-deprotection to produce 4b, H2A.X(22-142)A21C A135C S139ph and ESI-MS.
Upon completion of the reaction, the desulfurization reaction was initiated by addition of TCEP buffer, VA-044 and GSH as described above. The reaction was monitored by RP-HPLC and ESI-MS and upon reaching completion, the product was purified by semipreparative RP-HPLC to yield the desired product, protein 6. Protein 6 was further analyzed by analytical RP-HPLC (Figure 2d ) and ESI-MS (Figure 2e ), lyophilized and stored at -20°C for later use in octamer refolding. Ligation to produce 7, H2A.X K15ub
Synthesis
Purified, SUMO-deprotected 1c was ligated to the ubiquitylated H2A.X N-terminal peptide 5b, followed by desulfurization as described above. The product, 7, was purified by semipreparative RP-HPLC and was further analyzed by analytical RP-HPLC and ESI-MS (Figure S4d-f) followed by lyophilization for later use in octamer refolding. Cell cultures were grown at 37° C in LB media supplemented with 100 μg/mL ampicillin and 35 μg/mL chloramphenicol until an OD600 of 0.6. Protein expression was induced by addition of IPTG to a final concentration of 0.5 mM. Expression of the protein was allowed to continue until 3 h post-induction. Cells were harvested, cell pellets were resuspended in lysis buffer (20 mM Tris pH 7.5, 1 mM EDTA, 200 mM NaCl, 1 mM βME, 1 Roche EDTA-free protease inhibitor tablet / 50mL). Cells were lysed by freeze-thawing and sonication. The inclusion body pellet was washed twice with 7.5 mL of lysis buffer with 1% triton and once without triton.
Histones were resolubilized in resolubilization buffer (6 M GdmHCl, 20 mM Tris-HCl, 1 mM EDTA, 1 mM βME, pH 7.5), dialyzed into urea buffer (7M urea, 10 mM Tris-HCl, 1 mM EDTA, 0.1 M NaCl, 5 mM βME, pH 7.5) followed by purification by cation exchange (using a HiTrap SP HP 5 mL column). Collected fractions were analyzed by SDS-PAGE, followed by final purification using preparative RP-HPLC. Collected fractions were characterized by analytical RP-HPLC and ESI-MS, lyophilized and stored at -20° C until use in octamer refolding.
Histone octamer refolding
In a typical octamer refolding reaction, 0.4-1.5 mg of each of the pure lyophilized human histones were dissolved in unfolding buffer (6 M GmdHCl, 10 mM Tris-HCl, 5 mM DTT, pH 7.5). The exact concentration was determined by UV spectroscopy, using the following extinction coefficients: ε 280nm,H2A = 4470 M . Equimolar amounts of H3 and H4
were then mixed along with 1.05 equivalents of H2A and H2B at 1 mg ml -1 and octamers were refolded by dialysis against refolding buffer (2 M NaCl, 10 mM Tris-HCl, 1 mM EDTA, 5 mM DTT, pH 7.5). The refolded octamers were subsequently purified by gel filtration on a Superdex S200 10/300GL column. Collected fractions were analysed by SDS-PAGE, and octamer containing fractions were pooled and concentrated to ~50µM octamer concentration ( Figure S6) . Finally, glycerol was added to a final concentration of 50% (v/v), concentrations were determined by UV spectroscopy and octamer stocks were stored at -20° C.
Convergent DNA ligations for 12x601 arrays
Chromatin DNA was produced as shown in Figure S5a and described in ref. 5 . Briefly, recombinant pieces recP1 and recP5 were expressed in bacterial cells and purified. P2, P3 and P4 were produced by PCR reactions and purified. Each piece was digested with the restriction enzymes BsaI-HF and DraIII-HF, which generate non-palindromic unique overhangs. Digested DNA fragments were purified by PEG precipitation to remove small fragments which may re-ligate. 
Chromatin array reconstitution on 12-mer DNA fragments and analysis
Chromatin assembly was performed, following ref 6 . Chromatin arrays were reconstituted on a scale of ~20 pmol (calculated based on nucleosome positioning sequences). Fluorescently labeled chromatin array DNA was mixed with equimolar MMTV buffer DNA (to avoid overloading the chromatin with octamers), NaCl was added to a final concentration of 2 M, followed by the addition of equimolar equivalents of histone octamers with or without modifications. The mixture was transferred to a micro-dialysis tube and dialyzed with a linear gradient from TEK2000 (TE buffer containing 2000 mM potassium chloride) to TEK10 over 16-18 h. The dialysis tube was transferred to 200-600 mL TEK10 for another 1 h of dialysis. The chromatin assembly mixture was further centrifuged at 21000 x g for 10 min and the supernatant was collected. The concentration of the crude assembly was finally determined by UV-VIS spectrometry. For gel analysis, 0.25-0.50 pmol of chromatin assembly sample was diluted to a volume of 10 µL with TEK10 and 25% sucrose was added to a final concentration of 5-7%. This was run in 0.7% agarose gels made with 0.25x TB and using the same as running buffer at 90 V for 90-100 min (Figure 3b) .
For ensemble FRET analysis, MMTV DNA and free MMTV nucleosomes had to be removed. To this end the crude assembly was mixed with an equal volume of 6 mM Mg 2+ for precipitation on ice for 10 min followed by 10 min centrifugation at 21000 x g. The supernatant was removed and the chromatin pellet was re-dissolved in a similar volume of TEK10 as present prior to addition of magnesium (Figure 3b) .
Chromatin assembly was assessed by ScaI-digestion of the arrays, liberating individual nucleosomes. Chromatin arrays were mixed with an equal volume of 1 x CutSmart buffer and 10 U of ScaI-HF restriction enzyme, followed by digestion for 5-7 h at room temperature. ScaI digests were analyzed by agarose gel-electophoresis or native PAGE using 0.5% TBE gels. Gels were visualized first in fluorescence channels and then stained with GelRed for visualization of both fluorescing and non-fluorescent DNA and nucleosomal/chromatin bands. Only chromatin arrays that did show full nucleosomal occupancy in ScaI digest samples were used for further experiments.
Ensemble FRET measurements on chromatin
Fluorescence spectra were recorded on a Fluorolog-3 fluorescence spectrometer. The settings used on the fluorescence spectrometer were: 575 nm excitation with 4 nm slit width and detection of the fluorescence emission in the range 585-700 nm with 5 nm slit width. Chromatin samples isolated after magnesium precipitation were diluted to a final volume of typically 220-250 µL resulting in a concentration giving a spectral count of around 90000-130000 cps for the donor prior to compaction. The sample was then split in 4 x 50 µL volumes. TEK10 and Mg 2+ from stocks of 10 mM or 50 mM was added along with TEK10 to a final volume of 55 µL 5 min prior to measuring. After standing 5 min, the sample was transferred to the fluorescence micro-cuvette for measurement of the spectra twice. This was done for all the samples in the range 0-4 mM Mg 2+ ( Figure S7 ).
Preparing of flow chambers for single-molecule TIRF
Flow chambers for TIRF experiments were prepared following refs. 6, 7 . Briefly, borosilicate glass slides with 2 rows of 4 holes and borosilicate coverslips were sonicated in glass containers for 20 min in ultra-pure water, then in acetone and ethanol. They were cleaned in piranha solution (25% v/v H 2 O 2 and 75% v/v H 2 SO 4 ) in the same glass containers for 1h followed by washing with water until reaching neutral pH again. A 500 mL
Erlenmeyer flask was cleaned in the same way. The flask, coverslips and slides were all sonicated in acetone for 10 min. 3% v/v (3-aminopropyl)triethoxysilane was prepared in acetone in the flask and used to immerse the slides and coverslips, followed by a 20 min incubation. The slides and coverslips were then washed in ultra-pure water and dried with N 2 . On each slide, four flow-chambers were assembled from one glass slide and one coverslip separated by double-sided 0.12 mm tape. Open ends were sealed with epoxy glue and the silanized slides stored under vacuum in the freezer until use.
Before measurements, the flow chambers were passivated by attachment of a PEG brush. To this end, the silanized flow chambers were fitted with pipette tips as inlet reservoir and outlet sources in each of the 2x4 holes. The tips were glued in place with epoxy glue. Subsequently, 350 µL of 0.1 M tetraborate buffer at pH 8.5 was used to dissolve ~1 mg of biotin-mPEG(5000kDa)-SVA, and 175 µL from this was transferred to 20 mg mPEG(5000kDa)-SVA to generate a transparent clouding-point solution after 10 s of centrifugation.
This was mixed to homogeneity with a pipette and centrifuged again for 10 s before 40-45 µL aliquots were loaded into each of the four channels in the flow chamber. The PEGylation reaction was allowed to continue for the next 2½-4 h, after which the solution was washed out with degassed ultra-pure water.
smTIRF measurements
Measurements were performed as described before 5 . Briefly, imaging was carried out with a micro-mirror TIRF system 1 . For each experiment, the flow chambers were washed with 200-300 µL T50 (10 mM Tris-HCl, pH 8, 50 mM NaCl), followed by incubation with 50 µL 0.2 mg mL -1 neutravidin for 5 min. After a wash with 400-500 µL T50, 0.5-2 µL of chromatin assembly reaction at a concentration of 5-40 ng µL -1 was loaded into the chamber. Chromatin was loaded until reaching a density of 150-400 chromatin arrays in a 25 x 50 µm field of view. The channel was washed with T50 followed by exchange to imaging buffer (40 mM KCl, 50 mM Tris-HCl, 2 mM Trolox, 2 mM nitrobenzyl alcohol (NBA), 2 mM cyclooctatetraene (COT), 10% glycerol and 3.2% glucose) supplemented with GODCAT (100 x stock solution: 165 UmL -1 glucose oxidase, 2170 UmL -1 catalase). For imaging, a programmed sequence was employed to switch the field of view to a new area followed by adjusting the focus. Then the camera was triggered to acquire 1300-2000 frames with 532 nm excitation and 100 ms time-resolution followed by a final change to 640 nm excitation.
From acquired movies, the background was extracted in ImageJ using a rolling ball algorithm.
Trace extraction and analysis was performed in custom-written MATLAB software. The donor and the acceptor images were non-isotropically aligned using a transformation matrix generated from 8-10 sets of peaks appearing in both the donor and the acceptor channels. Peaks were automatically detected in the initial acceptor image prior to donor excitation and the same peaks were selected in the donor channel. Peaks tightly clustered, close to the edges or above a set intensity threshold in either the donor or the acceptor channels indicating aggregation were removed from analysis. The analysis was then limited to the peaks appearing in both the donor and the acceptor channel and these traces were extracted for further analysis.
From traces of donor-(F D ) and acceptor (F A ) fluorescence emission intensity, FRET efficiency (E FRET ) traces are calculated as follows: 
